Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis

Open access
Gutiérrez, N C, Castellanos, M V, Martín, M L, Mateos, M V, Hernández, J M, Fernández, M, Carrera, D, Rosiñol, L, Ribera, J M, Ojanguren, J M, Palomera, L, Gardella, S, Escoda, L, Hernández-Boluda, J C, Bello, J L, de la Rubia, J, Lahuerta, J J, San Miguel, J F, on behalf of GEM/PETHEMA Spanish Group · 2007 · Leukemia

Abstract

Fluorescence in situ hybridization (FISH) has become a powerful technique for prognostic assessment in multiple myeloma (MM). However, the existence of associations between cytogenetic abnormalities compels us to re-assess the value of each abnormality. A total of 260 patients with MM at the time of diagnosis, enrolled in the GEM-2000 Spanish transplant protocol, have been analyzed by FISH in order to ascertain the independent influence on myeloma prognosis of IGH translocations, as well as RB and P53 deletions. Survival analyses showed that patients with t(4;14), RB or P53 deletions had a significantly shorter survival than patients without these abnormalities. However, patients with RB deletions without other abnormalities in FISH analysis, displayed a similar outcome to those patients without genetic changes by FISH (46 vs 54 months, P=0.3). In the multivariate analysis the presence of t(4;14), RB deletion associated with other abnormalities, age >60 years, high proportion of S-phase cells and advanced stage of the disease according to the International Staging System retained their independent prognostic influence. In summary, RB deletion as a sole abnormality does not lead to a shortening in the survival of MM patients, whereas t(4;14) confers the worst prognosis in MM patients treated with high-dose chemotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.leu.2404413

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 185

Metadata

Authors
Gutiérrez, N. C., Castellanos, M. V., Martín, M. L., Mateos, M. V., Hernández, J. M., Fernández, M., Carrera, D., Rosiñol, L., Ribera, J. M., Ojanguren, J. M., Palomera, L., Gardella, S., Escoda, L., Hernández-Boluda, J. C., Bello, J. L., de la Rubia, J., Lahuerta, J. J., San Miguel, J. F., & on behalf of GEM/PETHEMA Spanish Group
Venue
Leukemia
Published
2006-10-05
Volume
21
Issue
1
Pages
143-150
ISSN
  • 0887-6924 (ISSN-L)
  • 1476-5551
OpenAlex
W2063697325
Cited by
185
References
1
FWCI
7.56
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis. https://app.cochat.ai/papers/10.1038/sj.leu.2404413
The paper
Gutiérrez, N. C., Castellanos, M. V., Martín, M. L., Mateos, M. V., Hernández, J. M., Fernández, M., Carrera, D., Rosiñol, L., Ribera, J. M., Ojanguren, J. M., Palomera, L., Gardella, S., Escoda, L., Hernández-Boluda, J. C., Bello, J. L., de la Rubia, J., Lahuerta, J. J., San Miguel, J. F., & on behalf of GEM/PETHEMA Spanish Group. (2007). Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis. Leukemia. https://doi.org/10.1038/sj.leu.2404413

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.